Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 12/2018

01-12-2018 | Original Article – Cancer Research

MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1

Authors: Xin-Long Ma, Feng Shang, Wei Ni, Jin Zhu, Bin Luo, Yu-Qi Zhang

Published in: Journal of Cancer Research and Clinical Oncology | Issue 12/2018

Login to get access

Abstract

Purpose

MicroRNAs (miRs) play an important role in many cancers and can affect cancer cell behavior, including glioma. This study aims at investigating the effects of miR-338-5p on the senescence, migration, invasion, and apoptosis of glioma cells via MAPK-signaling pathway by binding to FOXD1.

Methods

Gene expression microarray analysis was performed to screen differentially expressed miRNAs associated with glioma. Glioma tissues and adjacent tissues were collected. siRNA, mimic, and inhibitor were introduced for investigating the tumor suppressor role of miR-338-5p in glioma. Proliferation, migration, invasion, senescence, cell-cycle distribution, and apoptosis after transfection were detected by MTT assay, scratch test, Transwell assay, β-galactosidase staining, and flow cytometry, respectively.

Results

FOXD1 was identified as the up-regulated gene in glioma based on microarray data of GSE65626. FOXD1 was the target gene of miR-338-5p. Glioma tissues had increased expression of FOXD1, MEK-2, ERK-1, DAF, PCNA, and Bcl-2, and decreased expression of miR-338-5p and Bax. In cell experiments, after transfected with overexpressed miR-338-5p, higher expression of miR-338-5p, Bax, CD133, ZEB1, SOX2, SNAI1, and MMP2, but lower expression of FOXD1, MEK-2, ERK-1, Bcl-2, DAF, and PCNA were found accompanied with weaker proliferation, migration and invasion as well as stemness abilities but stronger senescence and higher apoptosis rate.

Conclusion

We found that overexpression of miR-338-5p suppresses glioma cell proliferation, migration, and invasion and accelerates its senescence and apoptosis by decreasing FOXD1 expression via inhibition of activation of MAPK-signaling pathway.
Appendix
Available only for authorised users
Literature
go back to reference Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1–11PubMed Alexiou GA, Tsiouris S, Kyritsis AP, Voulgaris S, Argyropoulou MI, Fotopoulos AD (2009) Glioma recurrence versus radiation necrosis: accuracy of current imaging modalities. J Neurooncol 95:1–11PubMed
go back to reference Ames H, Halushka MK, Rodriguez FJ (2017) miRNA regulation in gliomas: usual suspects in glial tumorigenesis and evolving clinical applications. J Neuropathol Exp Neurol 76:246–254PubMed Ames H, Halushka MK, Rodriguez FJ (2017) miRNA regulation in gliomas: usual suspects in glial tumorigenesis and evolving clinical applications. J Neuropathol Exp Neurol 76:246–254PubMed
go back to reference Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009) Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48:910–919PubMed Annabi B, Lachambre MP, Plouffe K, Sartelet H, Beliveau R (2009) Modulation of invasive properties of CD133+ glioblastoma stem cells: a role for MT1-MMP in bioactive lysophospholipid signaling. Mol Carcinog 48:910–919PubMed
go back to reference Besse A et al (2016) MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumour Biol J Int Soc Oncodev Biol Med 37:7719–7727 Besse A et al (2016) MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response. Tumour Biol J Int Soc Oncodev Biol Med 37:7719–7727
go back to reference Chen W, Qi J, Bao G, Wang T, Du CW, Wang MD (2015) Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol Med Rep 12:1515–1523PubMed Chen W, Qi J, Bao G, Wang T, Du CW, Wang MD (2015) Emerging role of microRNA-27a in human malignant glioma cell survival via targeting of prohibitin. Mol Med Rep 12:1515–1523PubMed
go back to reference Cheng P et al (2016) FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res 76:7219–7230PubMedPubMedCentral Cheng P et al (2016) FOXD1-ALDH1A3 signaling is a determinant for the self-renewal and tumorigenicity of mesenchymal glioma stem cells. Cancer Res 76:7219–7230PubMedPubMedCentral
go back to reference Cui H et al (2016) Methylation of the miR-126 gene associated with glioma progression. Fam Cancer 15:317–324PubMed Cui H et al (2016) Methylation of the miR-126 gene associated with glioma progression. Fam Cancer 15:317–324PubMed
go back to reference Erlich RB et al (2007) STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 55:1690–1698PubMed Erlich RB et al (2007) STI1 promotes glioma proliferation through MAPK and PI3K pathways. Glia 55:1690–1698PubMed
go back to reference Figarella-Branger D, Labrousse F, Mohktari K, Societe franc aise de n, Reseau de neuro-oncologie p (2012) Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Societe franc aise de neuropathologie. Reseau de neuro-oncologie pathologique. Annales de pathologie 32:318–327PubMed Figarella-Branger D, Labrousse F, Mohktari K, Societe franc aise de n, Reseau de neuro-oncologie p (2012) Guidelines for adult diffuse gliomas WHO grade II, III and IV: pathology and biology. Societe franc aise de neuropathologie. Reseau de neuro-oncologie pathologique. Annales de pathologie 32:318–327PubMed
go back to reference Foreman PM, Friedman GK, Cassady KA, Markert JM (2017) Oncolytic virotherapy for the treatment of malignant glioma. Neurother J Am Soc Exp Neurother 14:333–344 Foreman PM, Friedman GK, Cassady KA, Markert JM (2017) Oncolytic virotherapy for the treatment of malignant glioma. Neurother J Am Soc Exp Neurother 14:333–344
go back to reference Gao YF et al (2017) Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells. Oncol Rep 37:1196–1202PubMed Gao YF et al (2017) Silencing of Forkhead box D1 inhibits proliferation and migration in glioma cells. Oncol Rep 37:1196–1202PubMed
go back to reference Hall PA et al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294PubMed Hall PA et al (1990) Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162:285–294PubMed
go back to reference Hart MG, Garside R, Rogers G, Stein K, Grant R (2013) Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415 Hart MG, Garside R, Rogers G, Stein K, Grant R (2013) Temozolomide for high grade glioma. Cochrane Database Syst Rev 4:CD007415
go back to reference Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251PubMed Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241–251PubMed
go back to reference Hua FF et al (2017) MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway. Eur Rev Med Pharmacol Sci 21:5342–5352PubMed Hua FF et al (2017) MiRNA-338-3p regulates cervical cancer cells proliferation by targeting MACC1 through MAPK signaling pathway. Eur Rev Med Pharmacol Sci 21:5342–5352PubMed
go back to reference Jia Z et al (2018) Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Oncol Lett 15:8669–8680PubMedPubMedCentral Jia Z et al (2018) Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Oncol Lett 15:8669–8680PubMedPubMedCentral
go back to reference Jiang B, Chaichana K, Veeravagu A, Chang SD, Black KL, Patil CG (2017) Biopsy versus resection for the management of low-grade gliomas. Cochrane Database Syst Rev 4:CD009319PubMed Jiang B, Chaichana K, Veeravagu A, Chang SD, Black KL, Patil CG (2017) Biopsy versus resection for the management of low-grade gliomas. Cochrane Database Syst Rev 4:CD009319PubMed
go back to reference Karolak MJ, Guay JA, Oxburgh L (2018) Inactivation of Map3k7 in Foxd1-expressing cells results in loss of mesangial PDGFRbeta and juvenile kidney scarring. Am J Physiol Ren Physiol 315(2):F336–F344 Karolak MJ, Guay JA, Oxburgh L (2018) Inactivation of Map3k7 in Foxd1-expressing cells results in loss of mesangial PDGFRbeta and juvenile kidney scarring. Am J Physiol Ren Physiol 315(2):F336–F344
go back to reference Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta 1802:396–405PubMed Kim EK, Choi EJ (2010) Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta 1802:396–405PubMed
go back to reference Koga M et al (2014) Foxd1 is a mediator and indicator of the cell reprogramming process. Nat Commun 5:3197PubMed Koga M et al (2014) Foxd1 is a mediator and indicator of the cell reprogramming process. Nat Commun 5:3197PubMed
go back to reference Lei D, Zhang F, Yao D, Xiong N, Jiang X, Zhao H (2017) MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother (Biomedecine pharmacotherapie) 89:957–965 Lei D, Zhang F, Yao D, Xiong N, Jiang X, Zhao H (2017) MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1. Biomed Pharmacother (Biomedecine pharmacotherapie) 89:957–965
go back to reference Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20 Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20
go back to reference Li J, Jiang Z, Han F, Liu S, Yuan X, Tong J (2016) FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients. Oncotarget 7:25585–25592PubMedPubMedCentral Li J, Jiang Z, Han F, Liu S, Yuan X, Tong J (2016) FOXO4 and FOXD3 are predictive of prognosis in gastric carcinoma patients. Oncotarget 7:25585–25592PubMedPubMedCentral
go back to reference Liang Z et al (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817–824PubMed Liang Z et al (2010) Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817–824PubMed
go back to reference Lin F et al (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104:215–225PubMedPubMedCentral Lin F et al (2001) Tissue distribution of products of the mouse decay-accelerating factor (DAF) genes. Exploitation of a Daf1 knock-out mouse and site-specific monoclonal antibodies. Immunology 104:215–225PubMedPubMedCentral
go back to reference Liu WT, Huang CY, Lu IC, Gean PW (2013) Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neurooncology 15:1127–1141 Liu WT, Huang CY, Lu IC, Gean PW (2013) Inhibition of glioma growth by minocycline is mediated through endoplasmic reticulum stress-induced apoptosis and autophagic cell death. Neurooncology 15:1127–1141
go back to reference Liu DZ, Zhao H, Zou QG, Ma QJ (2017) MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma. Cancer Biomark Sect A Dis Mark 20:289–297 Liu DZ, Zhao H, Zou QG, Ma QJ (2017) MiR-338 suppresses cell proliferation and invasion by targeting CTBP2 in glioma. Cancer Biomark Sect A Dis Mark 20:289–297
go back to reference Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4:175–186PubMed Mamelak AN, Jacoby DB (2007) Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv 4:175–186PubMed
go back to reference Metcalfe SE, Grant R (2001) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 3:CD002034 Metcalfe SE, Grant R (2001) Biopsy versus resection for malignant glioma. Cochrane Database Syst Rev 3:CD002034
go back to reference Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL (2006) Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 65:1181–1188PubMed Mizoguchi M, Betensky RA, Batchelor TT, Bernay DC, Louis DN, Nutt CL (2006) Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival. J Neuropathol Exp Neurol 65:1181–1188PubMed
go back to reference Nakayama S et al (2015) FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. Anticancer Res 35:261–268PubMed Nakayama S et al (2015) FOXD1 expression is associated with poor prognosis in non-small cell lung cancer. Anticancer Res 35:261–268PubMed
go back to reference Nohata N, Goto Y, Gutkind JS (2017) Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet 62:87–96PubMed Nohata N, Goto Y, Gutkind JS (2017) Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer. J Hum Genet 62:87–96PubMed
go back to reference Peng Y, Liu YM, Li LC, Wang LL, Wu XL (2014) MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PloS One 9:e94422PubMedPubMedCentral Peng Y, Liu YM, Li LC, Wang LL, Wu XL (2014) MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PloS One 9:e94422PubMedPubMedCentral
go back to reference Reinhardt A et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica 136(2):273–291PubMed Reinhardt A et al (2018) Anaplastic astrocytoma with piloid features, a novel molecular class of IDH wildtype glioma with recurrent MAPK pathway, CDKN2A/B and ATRX alterations. Acta Neuropathologica 136(2):273–291PubMed
go back to reference Reuss D, von Deimling A (2009) Hereditary tumor syndromes and gliomas. Recent results in cancer research. Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 171:83–102PubMed Reuss D, von Deimling A (2009) Hereditary tumor syndromes and gliomas. Recent results in cancer research. Fortschritte der Krebsforschung Progres dans les recherches sur le cancer 171:83–102PubMed
go back to reference Song WS et al (2016) Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc 79:538–545PubMed Song WS et al (2016) Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. J Chin Med Assoc 79:538–545PubMed
go back to reference Tan PG, Li ZQ, Cai WQ, Lu JP, Xie FS, Weng Y (2003) Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance. Aizheng Chin J Cancer (Ai zheng) 22:1077–1080 Tan PG, Li ZQ, Cai WQ, Lu JP, Xie FS, Weng Y (2003) Expression of nm23 and proliferating cell nuclear antigen (PCNA) in human brain gliomas and their significance. Aizheng Chin J Cancer (Ai zheng) 22:1077–1080
go back to reference Tanboon J, Williams EA, Louis DN (2016) The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol 75:4–18PubMed Tanboon J, Williams EA, Louis DN (2016) The diagnostic use of immunohistochemical surrogates for signature molecular genetic alterations in gliomas. J Neuropathol Exp Neurol 75:4–18PubMed
go back to reference Toomey CB, Cauvi DM, Pollard KM (2014) The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease. Autoimmune Dis 2014:452853PubMedPubMedCentral Toomey CB, Cauvi DM, Pollard KM (2014) The role of decay accelerating factor in environmentally induced and idiopathic systemic autoimmune disease. Autoimmune Dis 2014:452853PubMedPubMedCentral
go back to reference Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B (2013) Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 30:373PubMed Wang S, Lu S, Geng S, Ma S, Liang Z, Jiao B (2013) Expression and clinical significance of microRNA-326 in human glioma miR-326 expression in glioma. Med Oncol 30:373PubMed
go back to reference Wang F et al (2015a) Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res 7:607–615PubMedPubMedCentral Wang F et al (2015a) Activation of toll-like receptor 2 promotes invasion by upregulating MMPs in glioma stem cells. Am J Transl Res 7:607–615PubMedPubMedCentral
go back to reference Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y (2015b) MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol 8:337–344PubMedPubMedCentral Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y (2015b) MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol 8:337–344PubMedPubMedCentral
go back to reference Wang SS et al (2016) CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation. Oncotarget 7:29051–29062PubMedPubMedCentral Wang SS et al (2016) CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation. Oncotarget 7:29051–29062PubMedPubMedCentral
go back to reference Wang R et al (2018) Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. OncoTargets Ther 11:1183–1192 Wang R et al (2018) Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma. OncoTargets Ther 11:1183–1192
go back to reference Weller M et al (1997) Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19:459–470PubMed Weller M et al (1997) Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53. Neurol Res 19:459–470PubMed
go back to reference Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992PubMed Zhang L, Yu J, Park BH, Kinzler KW, Vogelstein B (2000) Role of BAX in the apoptotic response to anticancer agents. Science 290:989–992PubMed
go back to reference Zhang ZZ, Shields LB, Sun DA, Zhang YP, Hunt MA, Shields CB (2015) The art of intraoperative glioma identification. Front Oncol 5:175PubMedPubMedCentral Zhang ZZ, Shields LB, Sun DA, Zhang YP, Hunt MA, Shields CB (2015) The art of intraoperative glioma identification. Front Oncol 5:175PubMedPubMedCentral
go back to reference Zhao YF et al (2015) FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem Biophys Res Commun 456:232–237PubMed Zhao YF et al (2015) FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem Biophys Res Commun 456:232–237PubMed
go back to reference Zhao Y, Chen J, Wei W, Qi X, Li C, Ren J (2018) The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduct Target Ther 3:3PubMedPubMedCentral Zhao Y, Chen J, Wei W, Qi X, Li C, Ren J (2018) The dual-inhibitory effect of miR-338-5p on the multidrug resistance and cell growth of hepatocellular carcinoma. Signal Transduct Target Ther 3:3PubMedPubMedCentral
go back to reference Zolota V et al (2014) Mitogen-activated protein kinases in gliomas and correlation with patients’ prognosis. Acta Neurol Scand 129:226–233 Zolota V et al (2014) Mitogen-activated protein kinases in gliomas and correlation with patients’ prognosis. Acta Neurol Scand 129:226–233
Metadata
Title
MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1
Authors
Xin-Long Ma
Feng Shang
Wei Ni
Jin Zhu
Bin Luo
Yu-Qi Zhang
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Journal of Cancer Research and Clinical Oncology / Issue 12/2018
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-018-2745-y

Other articles of this Issue 12/2018

Journal of Cancer Research and Clinical Oncology 12/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.